Related references
Note: Only part of the references are listed.KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease Abstracts
[Anonymous]
KIDNEY INTERNATIONAL (2021)
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
Cora E. Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
On the empirical choice of the time window for restricted mean survival time
Lu Tian et al.
BIOMETRICS (2020)
Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes
David E. Kloecker et al.
ANNALS OF INTERNAL MEDICINE (2020)
Subtleties in the interpretation of hazard contrasts
Torben Martinussen et al.
LIFETIME DATA ANALYSIS (2020)
Evidence-Based Risk Communication A Systematic Review
Daniella A. Zipkin et al.
ANNALS OF INTERNAL MEDICINE (2014)
Predicting the restricted mean event time with the subject's baseline covariates in survival analysis
Lu Tian et al.
BIOSTATISTICS (2014)
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
The Hazards of Hazard Ratios
Miguel A. Hernan
EPIDEMIOLOGY (2010)
Causal inference on the difference of the restricted mean lifetime between two groups
PY Chen et al.
BIOMETRICS (2001)
Share Paper
